Home » PENWEST PHARMA POSTS Q1 LOSS/SHARE NARROWER THAN ESTIMATES
PENWEST PHARMA POSTS Q1 LOSS/SHARE NARROWER THAN ESTIMATES
Penwest Pharmaceuticals Co. reported a first quarter net loss of $6.3 million or $0.28 per share, compared with a net loss of $8.9
million or $0.41 per share in the same quarter last year. Total revenues for the first quarter were $965,000, compared with $982,000 in the year-ago quarter.
Trading Markets
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May